Astellas Pharma
About
Astellas Venture Management (AVM) is the corporate venture capital arm of Astellas Pharma, Inc. AVM supports early-stage biotechnology companies focused on therapeutics programs and platform technologies for drug discovery and development. Their investment strategy aims to enhance Astellas' R&D pipeline or catalyze new directions in discovery research, acting as a strategic investor and potential liaison for future collaborations.
Key facts
- Website
- astellasventure.com
- Headquarters
- Brisbane, USA
- Portfolio companies
- 1
- Stages
- ["Seed""Early Stage""Pre-Seed"]
- Cheque size
- $19M to $19M
- Sector focus
- BiotechnologyDrug DiscoveryTherapeuticsHealthcareGenetics
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 10 Jul 2024 | Sakana AI | Undisclosed round | $19M |
Astellas Pharma scores 28. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
What companies has Astellas Pharma invested in?
Astellas Pharma has invested in Sakana AI.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Astellas Pharma

